Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II

BACKGROUND: The optimum diagnostic test method for Clostridioides difficile infection (CDI) remains controversial due to variation in accuracy in identifying true CDI. This post hoc analysis examined the impact of CDI diagnostic testing methodology on efficacy outcomes in phase 3 MODIFY I/II trials....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Wilcox, Mark H, Rahav, Galia, Dubberke, Erik R, Gabryelski, Lori, Davies, Kerrie, Berry, Claire, Eves, Karen, Ellison, Misoo C, Guris, Dalya, Dorr, Mary Beth
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Major Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6677672/
https://ncbi.nlm.nih.gov/pubmed/31375837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz293
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados